Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

ADXN
Addex Therapeutics Ltd
stock NASDAQ ADR

At Close
Jul 9, 2025
9.29USD-2.007%(-0.19)5,294
0.00Bid   0.00Ask   0.00Spread
Pre-market
0.00USD-100.000%(-9.48)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
9.93M
Headquarters
Plan Les Ouates, Geneve, Switzerland
Industry
Biotechnology
Last Split
Oct 23, 20231for20reverse
ADXN Stats
Avg. Vol. 10 Day
26,452
Avg. Vol. 30 Day
12,165
Employees
24
Market Cap
9,931,999
Shares Out.
1,069,141
On/Off Exchange
68%/32%
6 Month Beta
-0.11
1 Year Beta
-0.19
2 Year Beta
-0.28
3 Year Beta
-0.45
52 Week Low
6.51
52 Week High
13.27
SMA50
8.30
SMA200
8.59
1 Week
+1.75%
1 Month
-7.61%
3 Month
+35.23%
6 Month
+23.53%
1 Year
+11.92%
2 Year
-22.20%
5 Year
-95.56%
Profile
addex therapeutics is pioneering discovery and development of an emerging class of oral small molecule drugs, called allosteric modulators, which can be exquisitely selective for their intended target and confer significant therapeutic advantages over conventional "orthosteric" small molecule or biological drugs. the company uses its proprietary discovery platform to address receptors and other proteins that have been undruggable for conventional drug discovery methods, including g-protein coupled receptors (gpcrs), receptor tyrosine kinases (rtks) and cytokine receptors, such as the tnf receptor superfamily. many such targets have been widely recognized as attractive for modulation of important diseases with unmet medical needs, but have remained inaccessible to small molecule drug discovery. the company's two lead products are: dipraglurant (adx48621), an mglur5 negative allosteric modulator, or nam, which reduced parkinson's disease levodopa-induced dyskinesia (pd-lid) in a phase ii

ADXN Stock Summary

Addex Therapeutics Ltd (NASDAQ:ADXN) stock price today is $9.29, and today's volume is 5,294. ADXN is down -2.007% today. The 30 day average volume is 12,165. ADXN market cap is 9.93M with 1,069,141 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC